Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Signs up Bioke as Benelux Distributor for BioMark

NEW YORK (GenomeWeb News) - Fluidigm said Thursday that under a new agreement the Dutch company Bioke is the exclusive distributor for Fluidigm’s BioMark PCR and genotyping system in the Netherlands, Luxembourg, and Belgium.
 
Fluidigm said the BioMark system offers performance improvements over standard RT-PCR systems because it is based on nanofluidic chips with preprogrammed fluidic networks that “automatically combine sets of samples with sets of PCR assays.”
 
The company said each BioMark array generates 2,304 PCR assays, but needs only 96 pipetting steps -- 1/40 the steps required by 384-well systems.
 
Financial terms of the agreement were not released.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.